Home About Us Writing a Scientific Article Author's Instruction Contact us
 

MERIT RESEARCH JOURNAL OF MEDICINE AND MEDICAL SCIENCES (MRJMMS) (ISSN: 2354-323X)

 
 

/  /    MRJMMS Home   /   /    About MRJMMS    /  /    Submit Manuscripts    /  /      Call For Articles      / /     Editorial Board     / /    Archive     / /    Author's Guide  /  /

 
 


June 2020 Vol. 8 No.6

Other viewing option


Abstract
Full text
Reprint (PDF) (155 KB)

Search Pubmed for articles by:
 

Mathkhor AJ
Abdullah AH

Other links:
PubMed Citation
Related articles in PubMed




















































































































































































































 

Merit Research Journal of Medicine and Medical Sciences (ISSN: 2354-323X) Vol. 8(6) pp. 284-286, June, 2020 

Copyright © 2020 Merit Research Journals
DOI: 10.5281/zenodo.3908639


Case Report

Etanercept Induced Bullous Pemphigoid Skin Lesion in Rheumatoid Arthritis: A Case Report

 
 
 

Abdulsatar J. Mathkhor1*, Jinan Q. Mohammed2 and Abdulnasser H. Abdullah3

 

1Rheumatologist. Rheumatology unit in Basra Teaching Hospital Basra. Iraq
2Dermatologist. Dermatology unit in Basra Teaching Hospital Basra. Iraq
3Rheumatologist, Rheumatology unit in Al sader Teaching Hospital, Basra. Iraq

*Corresponding author's E-mail: amathkhoor@yahoo.co.uk

Received: 04 June 2020  I  Accepted: 24 June 2020 I Published: 28 June 2020   I  Article ID: MRJMMS-20-098
Copyright © 2020 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0.

 

Abstract

 

Tumor necrosis factor-alpha (TNF-α) is a proinflammatory cytokine produced predominantly by activated macrophages, and involved in the up-regulation of inflammatory reactions, and plays a pivotal role in the pathogenesis of rheumatoid arthritis and some other autoimmune disorders. Since their introduction anti-TNF-α agents have been revolutionized the treatment of these disorders. However, some adverse events such as skin reaction, hypersensitivity, infection, reactivation of tuberculosis, and various autoimmune diseases can occur in patients using these agents. In this report, we present a female case who was diagnosed as bullous pemphigoid while receiving etanercept for treatment of rheumatoid arthritis.

Keywords: Anti-tumor necrosis factoralpha, Bullous pemphigoid, Rheumatoid arthritis





































 







 








 





















 









































































 










 







































 










 

 
 
   
   
   
   
   
   
   
   
   
   
   
 
 
 
 
 
 
 
 
   
 
                         

Merit Research Journals© 2020 || Advertisement | Privacy policy.